Refine by
Antibiotic Use Articles & Analysis
62 news found
The suite of products now includes saccharides, flavonoids, terpenoids, phenylpropanoids, antibiotics, phenols, steroids, and quinones, all of which are invaluable in modern scientific and industrial fields. ...
The Centers for Disease Control and Prevention (CDC) warns these bacteria are constantly finding new ways to avoid the effects of the antibiotics used to treat those infections. Vancomycin-resistant enterococci (VRE) is the name for the bacteria resistant to the antibiotic known as vancomycin. When the CDC released the 2019 ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, unveils the addition of the reliable Daptomycin ReadyMade™ Solution to its growing portfolio of innovative products to power up spectrum and microbiology applications. Daptomycin is an essential antibiotic used in the treatment ...
First, to raise specific immunity against one of the most important antibiotic-resistant bacteria in humans populations at hjgh-risk of development of antibiotic-resistant infections. And second, deliver to the porcine industry a vaccine to prevent infections of one of the most important causative agents of respiratory diseases in piglets, for reduction of the ...
[ii] Patients undergoing major surgeries like hip or knee replacements face the risk of life-threatening infections – with the majority of these related to the patients’ own microflora. In the US alone, the annual cost of treating PJIs is estimated at $1.62 ...
By combining our respective skillsets, we believe we can not only use diagnostic and surveillance data to help healthcare professionals make better diagnoses, but also expand our options to treat AMR in the future, by targeted repurposing of key antibiotics. ...
The prespecified immunogenicity endpoints of the Phase 2 portion of the study include an assessment of the induction of antibody responses, using immunoglobulin G (IgG) and opsonophagocytic activity (OPA), at each of the three VAX-24 doses and compared to Prevnar 20™ and, for the additional four serotypes contained in VAX-24 and Pneumovax® 23 but not in Prevnar ...
In fact, this precision approach garnered so much attention that d’Herelle and George Eliava co-founded an institute in Tbilisi, Georgia, in 1923 that was dedicated to studying bacteriophages and clinical use of phage therapies. However, this movement’s momentum quickly fizzled out after the discovery of the first antibiotic, penicillin, in 1928. ...
Expression vectors inserted with antibiotic resistance genes are mainstream recombinant expression systems that use antibiotics during fermentation to avoid the growth and domination of anaplastic granulocytes. ...
The prespecified immunogenicity endpoints of the Phase 2 portion of the study include an assessment of the induction of antibody responses, using immunoglobulin G (IgG) and opsonophagocytic activity (OPA), at each of the three VAX-24 doses and compared to Prevnar 20™ and, for the additional four serotypes contained in VAX-24 and Pneumovax® 23 but not in Prevnar ...
The Veterans Health Administration (VHA) is the largest integrated health care system in the US, providing care at nearly 1,300 healthcare facilities to over 9 million Veterans enrolled in the VA health care program. ...
The GRAM paper is the most comprehensive study about the global incidence of antibiotic-resistant bacteria. The relevance of this study is that finally gives a clear face, based on data, to the AMR crisis. ...
Pneumococci also cause over 50% of all cases of bacterial meningitis in the United States. Antibiotics are used to treat pneumococcal disease, but some strains of the bacteria have developed resistance to treatments. ...
Cold plasma treatment reduces the use of antibiotics or cortisone and does not cause allergic side effects or pain. ...
Following 11 studies across France and England comprising over 1,400 clinical positive blood culture samples, yielding overall accuracy of 97.8%, and in tandem with the commencement of clinical and analytical studies in preparation for 510(k) submission to the FDA, Specific’s commercial team will be engaging with leading lab directors across the US to introduce them to the ...
While we would like to reduce unwarranted use of antibiotics we do not want to leave a bacterial infection untreated. ...
ByMeMed
Rapid and accurate point-of-care results create a better workflow, and can play a pivotal role in preventing the misuse of antibiotics by enabling clinicians to select the most effective treatment for the condition. Appropriate use of antibiotics can improve patient health, reduce health care costs, and prolong the utility of effective ...
ViraBac EZ is intended to help physicians quickly and accurately determine whether to prescribe antibiotics in ambulatory settings. The test will use a capillary blood sample, ideal for use in primary care, urgent care and other outpatient clinical settings. ...
The primary target population in need will be individuals affected by chronic lung problems in high risk of developing antibiotic-resistant infections by these bacteria. The presentation of Dr. Infante was part of a session of pipeline updates by companies funded by the CARB-X organization (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator; ...
MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research and development of novel antibiotics for the treatment of serious bacterial infections, today announced the successful completion of a growth financing round raised via a private placement to European strategic investors. The funds raised will primarily be used to finance ...